Disease due to infection by the human immunodeficiency virus (HIV) continues to offer unprecedented challenges to the health sciences and biology, along with equally extraordinary opportunities for original investigation and discovery. The epidemic and its consequences have profoundly and irrevocably affected all aspects of biomedical science and health-care practice, including dentistry. AIDS and HIV infection cause a wide range of serious oral lesions which we have investigated for several years. This renewal application proposes a series of integrated and multidisciplinary, yet focused and specific, studies which build on the achievements of the first four years of the Oral AIDS Center at the University of California, San Francisco. The proposal is submitted by a group of clinical, epidemiological and laboratory investigators whose coordinated research on oral manifestations of AIDS/HIV infection has been innovative and productive. It proposes new approaches in response to the changing challenges posed by the epidemic. There is need to understand the changing demographics of the epidemic; changes in the epidemiology of the oral lesions related to HIV infection; changes in the natural history of HIV infection; and the effects of continually changing therapy directed at HIV and at the consequences of HIV infection. We believe that the unique group of epidemiology cohorts and clinic populations to which we have access, plus our proven record of successful collaboration with these groups, make it highly likely that we can continue to answer important epidemiological questions, including many which have arisen during the course of the initial grant period. The two integrated molecular biological/clinical studies proposed will focus on the two commonest and most significant oral lesions of HIV infection, oral candidiasis and hairy leukoplakia. Oral candidiasis is one of the most prominent oral lesions of HIV disease, a significant indicator of CD4 numbers and a predictor of the development of AIDS. Yet there is little understanding of how Candida becomes pathogenic in the immunocompromised patient, or indeed, whether exogenous virulent strains are involved or not. We propose to explore the molecular biological basis of that pathogenicity with the ultimate goal of understanding opportunistic fungal infection in order to prevent and control it. Hairy leukoplakia (HL), caused by the Epstein-Barr virus (EBV), was first seen and is still predominantly found in HIV-infected people. We propose to explore the nature of EBV infection in HL and the relationship of the virus to the oral epithelial cell, using molecular biological and other approaches, with the goals of understanding the pathogenesis of HL and of contributing to the understanding of other EBV- related diseases. We thus propose a group of three integrated multidisciplinary studies based on the unusual, perhaps unique, opportunity presented by our group to explore the interface of oral disease, epidemiology and molecular pathology. These three coordinated components will be supported by the administrative and biostatistics core and by the clinical and laboratory core.

Agency
National Institute of Health (NIH)
Institute
National Institute of Dental & Craniofacial Research (NIDCR)
Type
Research Program Projects (P01)
Project #
5P01DE007946-09
Application #
2129931
Study Section
Special Emphasis Panel (SRC (17))
Project Start
1987-04-01
Project End
1997-04-30
Budget Start
1995-05-01
Budget End
1996-04-30
Support Year
9
Fiscal Year
1995
Total Cost
Indirect Cost
Name
University of California San Francisco
Department
Internal Medicine/Medicine
Type
Schools of Dentistry
DUNS #
073133571
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Dollard, Sheila C; Butler, Lisa M; Jones, Alison M Graves et al. (2010) Substantial regional differences in human herpesvirus 8 seroprevalence in sub-Saharan Africa: insights on the origin of the ""Kaposi's sarcoma belt"". Int J Cancer 127:2395-401
Chang, W L William; Barry, Peter A; Szubin, Richard et al. (2009) Human cytomegalovirus suppresses type I interferon secretion by plasmacytoid dendritic cells through its interleukin 10 homolog. Virology 390:330-7
Sroussi, Herve Y; Köhler, Gerwald A; Agabian, Nina et al. (2009) Substitution of methionine 63 or 83 in S100A9 and cysteine 42 in S100A8 abrogate the antifungal activities of S100A8/A9: potential role for oxidative regulation. FEMS Immunol Med Microbiol 55:55-61
Szubin, Richard; Chang, W L William; Greasby, Tamara et al. (2008) Rigid interferon-alpha subtype responses of human plasmacytoid dendritic cells. J Interferon Cytokine Res 28:749-63
Chidzonga, Midion M; Mwale, Magda; Malvin, Kathy et al. (2008) Oral candidiasis as a marker of HIV disease progression among Zimbabwean women. J Acquir Immune Defic Syndr 47:579-84
Owotade, F J; Shiboski, C H; Poole, L et al. (2008) Prevalence of oral disease among adults with primary HIV infection. Oral Dis 14:497-9
Haas-Stapleton, Eric J; Lu, Yan; Hong, Song et al. (2007) Candida albicans modulates host defense by biosynthesizing the pro-resolving mediator resolvin E1. PLoS One 2:e1316
Tugizov, Sharof; Herrera, Rossana; Veluppillai, Piri et al. (2007) Epstein-Barr virus (EBV)-infected monocytes facilitate dissemination of EBV within the oral mucosal epithelium. J Virol 81:5484-96
Hodgson, T A; Greenspan, D; Greenspan, J S (2006) Oral lesions of HIV disease and HAART in industrialized countries. Adv Dent Res 19:57-62
Palefsky, J (2006) Biology of HPV in HIV infection. Adv Dent Res 19:99-105

Showing the most recent 10 out of 124 publications